Skip to main content

Table 1 Patient characteristics for patients with grass pollen allergy with and without sublingual immunotherapy (SLIT)

From: HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study

  Total (n = 295) SLIT (n = 177) Reference population (n = 118)
Men/women 49%/51% 55%/45% 41%/59%
Age, mean years (SD) 36.5 (11.1) 37.2 (11.6) 35.3 (10.2)
Employed, n (%) 235 (80%) 146 (82%) 89 (75%)
Daily smoker, n (%) 6 (2%) 5 (3%) 1 (< 1%)
Previous smoker, n (%) 52 (18%) 37 (21%) 15 (13%)
Self-reported asthma, n (%) 97 (33%) 57 (32%) 40 (34%)
Self-reported eczema, n (%) 53 (18%) 30 (17%) 23 (19%)
Self-reported use of medications against nasal and or eye problem during the last year, n (%) 282 (96%) 168 (95%) 114 (97%)
Out of thosea
 Systemic corticosteroids, n (%) 69 (24%) 24 (14%) 45(41%)
 Nasal steroid spray, n (%) 224 (79%) 122 (73%) 102 (89%)
 Nasal antihistamine spray, n (%) 92 (33%) 41 (24%) 51 (45%)
 Antihistamine, oral, n (%) 245 (87%) 138 (82%) 107 (94%)
  1. aTotal (n = 282), SLIT (n = 168) Reference population (n = 114)